Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Smithfield makes move on market for pig-human transplants

      Smithfield makes move on market for pig-human transplants

      supriya kashyap kashyap12 April 2017 9:11 AM IST
      Smithfield Foods, the world's largest pork producer, has established a separate bioscience unit to expand its role in supplying pig parts for medical...
      UK cost agency turns down Bristol drug for head and neck cancer

      UK cost agency turns down Bristol drug for head and neck cancer

      supriya kashyap kashyap11 April 2017 4:06 PM IST
      Britain's healthcare cost-effectiveness watchdog NICE said that Bristol-Myers Squibb's immunotherapy drug Opdivo was not worth using on the state...
      Anti-dumping duty likely on Amoxycillin import from China

      Anti-dumping duty likely on Amoxycillin import from China

      supriya kashyap kashyap11 April 2017 11:48 AM IST
      New Delhi : India may impose anti-dumping duty of up to USD 8.71 per kg on Amoxycillin, an anti-biotic medicine, from China to ringfence domestic...
      Glenmark gets USFDA nod for anti-cholesterol drug

      Glenmark gets USFDA nod for anti-cholesterol drug

      supriya kashyap kashyap11 April 2017 11:43 AM IST
      New Delhi : Drug firm Glenmark Pharmaceuticals said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used...
      USFDA issues 4 observations to Marksans Pharmas Verna plant

      USFDA issues 4 observations to Marksans Pharma's Verna plant

      supriya kashyap kashyap11 April 2017 11:43 AM IST
      New Delhi : Drug firm Marksans Pharma said the US health regulator has issued four observations after completing the inspection of its Verna facility...
      Religare to sell Religare Health Insurance to PE fund Rs 1,040 cr

      Religare to sell Religare Health Insurance to PE fund Rs 1,040 cr

      supriya kashyap kashyap10 April 2017 11:41 AM IST
      New Delhi : Religare Enterprises will sell its entire 80 per cent stake in Religare Health Insurance to a consortium of investors led by private...
      FDA allows marketing of first direct-to-consumer Gene Test

      FDA allows marketing of first direct-to-consumer Gene Test

      supriya kashyap kashyap10 April 2017 11:35 AM IST
      The US Food and Drug Administration allowed marketing of 23 and Me Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or...
      US regulator makes 2 observations at Neuland Labs facility

      US regulator makes 2 observations at Neuland Labs facility

      supriya kashyap kashyap10 April 2017 11:33 AM IST
      New Delhi : Drug firm Neuland Laboratories said the US health regulator has made two observations at its manufacturing facility in Hyderabad."The...
      Torrent soon to buy womens healthcare portfolio from Novartis

      Torrent soon to buy women's healthcare portfolio from Novartis

      supriya kashyap kashyap10 April 2017 11:32 AM IST
      Mumbai : Ahmedabad-based drug maker Torrent Pharmaceuticals is very close to finalise a deal for acquiring women's healthcare portfolio from Swiss...
      USFDA okays abridged clinical trial for antibiotic: Wockhardt

      USFDA okays abridged clinical trial for antibiotic: Wockhardt

      supriya kashyap kashyap10 April 2017 10:03 AM IST
      New Delhi : Drug firm Wockhardt said the US health regulator has agreed to abridged clinical trials for an antibiotic being developed by the...
      FDA rejects Mercks application to add heart safety data on diabetes drug labels

      FDA rejects Merck's application to add heart safety data on diabetes drug labels

      supriya kashyap kashyap10 April 2017 9:35 AM IST
      Merck said the U.S. Food and Drug Administration declined an application to include information on the labels of its diabetes drugs Januvia and...
      After PMO push, DoP fast tracks formulation of medical devices policy

      After PMO push, DoP fast tracks formulation of medical devices policy

      supriya kashyap kashyap9 April 2017 11:15 AM IST
      New Delhi : The Prime Minister’s Office has been pushing the Department of Pharmaceuticals to fast track formulation of the medical devices policy...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok